Full Press Release Details
Medical added to membership of Russell 3000 Index
Calif. - SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical"), a global franchise and provider of
services for aesthetic clinics, has been added as a member of the broad-market Russell 3000 Index, effective after the
US market opens on June 30, as part of the 2025 Russell indexes reconstitution.
in the Russell 3000 Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000
Index or small-cap Russell 2000 Index as well as the appropriate growth and value style indexes.
indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.
According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which
belong to FTSE Russell, the global index provider.
Bassett, CEO of FTSE Russell, An LSEG Business, comments:
Russell indexes have continuously adapted to the evolving dynamic US economy, and it's crucial to fully recalibrate the suite of
Russell US Indexes, ensuring the indexes maintain an accurate representation of the market. The transition to a semi-annual reconstitution
frequency from 2026 will ensure our indexes continue to represent the market and maintain the purpose of the index as a portfolio benchmark."
more information on the Russell 3000 Index and the Russell indexes reconstitution, go to the "Russell Reconstitution"
section on the FTSE Russell website.
Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment
centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited
to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and
training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals,
construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic
products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies,
trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee
clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.
For more information, visit https://sbc-holdings.com/
FTSE Russell, an LSEG Business
Russell is a global index leader that provides innovative benchmarking, analytics and data solutions for investors worldwide. FTSE Russell
calculates thousands of indexes that measure and benchmark markets and asset classes in more than 70 countries, covering 98% of the investable
market globally. FTSE Russell index expertise and products are used extensively by institutional and retail investors globally.
Approximately $18.1 trillion is benchmarked to FTSE Russell indexes. Leading asset owners, asset managers, ETF providers and investment
banks choose FTSE Russell indexes to benchmark their investment performance and create ETFs, structured products and index-based derivatives.
A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed
by independent committees of leading market participants. FTSE Russell is focused on applying the highest industry standards in index
design and governance and embraces the IOSCO Principles. FTSE Russell is also focused on index innovation and customer partnerships as
it seeks to enhance the breadth, depth and reach of its offering.
Russell is wholly owned by London Stock Exchange Group.
more information, visit FTSE Russell.
press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions,
but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently
uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with
respect to, among other things, the Company's product launch plans and strategies; growth in revenue and earnings; and business
prospects. In some cases, forward-looking statements can be identified by the use of words such as "may," "should,"
"expects," "anticipates," "contemplates," "estimates," "believes," "plans,"
"projected," "predicts," "potential," "targets" or "hopes" or the negative
of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current
only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are
difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees
of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking
statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement
is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge
from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in
global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading "Risk
Factors" and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"),
which are accessible on the SEC's website at www.sec.gov.
Medical Group Holdings Incorporated (Asia)
Fukui / Head of Investor Relations E-mail: ir@sbc-holdings.com
Zima / Managing Partner Email: bill.zima@icrinc.com